We offer complete solutions, combining products, recognized expertise and a full range of service to support laboratories and health care professionals in cervical cancer screening and clinical management of patients. Through the development of novel molecular oncology products, BD is focused on next-generation solutions in the field of cervical, ovarian and breast cancer.
|BD is proud to support the ECCA for the 6th Annual Cervical Cancer Prevention Week in Europe (22-28 January 2012). »|
|BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer »
|BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management »
Cancer Detection Archive»